Lifetree Center for Neuroscience Research
Committed to Central Nervous System Research
With the formation of Lifetree Center for Neuroscience Research (LCNSR) in 2008 Lifetree is dedicated to researching disorders of the Central Nervous System (CNS) which represent the second largest therapeutic area in terms of research and development (R&D) spending by biopharmaceutical and biotechnology companies, and account for more than 15 percent of the global cost of disease treatment. With such a large proportion of R&D resources dedicated to CNS disorders, companies developing products in this field need to choose a research partner with leading CNS expertise to maximize the impact of their investment.
Lifetree Clinical Research has a strong collaborative relationship with our local Alzheimer’s Association. The Association is very supportive of our Alzheimer’s research. In 2008, the association had contact with > 3,000 individuals in SLC with Alzheimer’s or their caregivers and encourages them to seek out clinical trials. Lifetree is allowed to post flyers with our contact information within the Association.
Our research facility in Salt Lake City, Utah is capable of executing studies involving new drug candidates for the treatment of:
CNS diseases and disorders, including:
Neurological Disorders:
- Alzheimers
- ADHD
- Cognitive Function
- Migraine Headaches
- Multiple Sclerosis
- Neuropathic Pain
- Seizure Disorders
- Sleep Disorders
Psychiatric Disorders:
- Anxiety Disorders
- Bi-Polar
- Major Depression
|
